Cargando…
The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316222/ https://www.ncbi.nlm.nih.gov/pubmed/32584817 http://dx.doi.org/10.1371/journal.pntd.0008259 |